Table 3.

Distribution of KIR genes among MM patients and healthy controls. A p-value < 0.05 was considered significant.

	Healthy	MM	p-value
N = 120	N = 34
2DL1	119 (99.2%)	33 (97.1%)	0.39
2DL2	73 (60.8%)	20 (58.8%)	0.49
2DL3	106 (88.3%)	28 (82.4%)	0.39
2DL4	120 (100%)	34 (100%)	1
2DL5A	38 (31.7%)	15 (44.1%)	0.22
2DL5B	45 (37.5%)	12 (35.3%)	0.49
2DS1	49 (40.8%)	17 (50.0%)	0.22
2DS2	73 (60.8%)	21 (61.8%)	0.54
2DS3	45 (37.5%)	15 (44.1%)	0.31
2DS4*001/002	20 (16.7%)	11 (32.4%)	0.04
2DS4*003/007	99 (82.5%)	24 (70.6%)	0.1
2DS5	34 (28.3%)	18 (52.9%)	0.007
3DL1	115 (95.8%)	32 (94.1%)	0.65
3DL2	120 (100%)	34 (100%)	–
3DL3	120 (100%)	34 (100%)	–
3DS1	45 (37.5%)	17 (51.5%)	0.11
2DP1	116 (96.7%)	33 (97.1%)	1
3DP*001/002/004	33 (27.5%)	10 (29.4%)	0.49
3DP1*003	120 (100%)	34 (100%)	–